Astrana Health (NASDAQ:ASTH) Shares Gap Down – What’s Next?

Astrana Health, Inc. (NASDAQ:ASTH) gapped down prior to trading on Tuesday . The stock had previously closed at $42.40, but opened at $41.00. Astrana Health shares last traded at $41.00, with a volume of 197 shares trading hands.

Wall Street Analysts Forecast Growth

Several research analysts have commented on the stock. TD Cowen assumed coverage on shares of Astrana Health in a report on Monday, October 14th. They set a “buy” rating and a $66.00 price objective for the company. Robert W. Baird raised their price target on Astrana Health from $67.00 to $86.00 and gave the company an “outperform” rating in a report on Wednesday, November 13th. BTIG Research upped their price objective on Astrana Health from $60.00 to $70.00 and gave the stock a “buy” rating in a report on Thursday, October 3rd. KeyCorp initiated coverage on shares of Astrana Health in a report on Friday, October 11th. They issued a “sector weight” rating for the company. Finally, Truist Financial upped their price target on shares of Astrana Health from $50.00 to $59.00 and gave the company a “buy” rating in a research note on Friday, August 9th. One analyst has rated the stock with a hold rating, six have given a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat.com, the company presently has an average rating of “Buy” and a consensus price target of $65.17.

Astrana Health Trading Up 0.9 %

The company’s 50 day simple moving average is $53.65 and its 200-day simple moving average is $47.98. The firm has a market cap of $2.41 billion, a P/E ratio of 32.97, a P/E/G ratio of 1.97 and a beta of 1.24. The company has a quick ratio of 1.91, a current ratio of 1.91 and a debt-to-equity ratio of 0.60.

Astrana Health (NASDAQ:ASTH) last posted its quarterly earnings data on Thursday, November 7th. The company reported $0.33 earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of $0.33. The company had revenue of $478.71 million during the quarter, compared to analysts’ expectations of $462.01 million. Astrana Health had a return on equity of 9.37% and a net margin of 3.63%. During the same quarter in the previous year, the business earned $0.47 EPS. As a group, research analysts predict that Astrana Health, Inc. will post 1.17 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

A number of hedge funds have recently made changes to their positions in the stock. Royce & Associates LP purchased a new stake in shares of Astrana Health in the third quarter valued at approximately $6,661,000. Amalgamated Bank purchased a new stake in shares of Astrana Health in the 3rd quarter worth $713,000. Principal Financial Group Inc. bought a new position in shares of Astrana Health during the 3rd quarter worth $13,383,000. Diamond Hill Capital Management Inc. bought a new stake in shares of Astrana Health in the third quarter valued at about $8,245,000. Finally, Summit Global Investments purchased a new stake in Astrana Health in the third quarter worth about $753,000. 52.77% of the stock is currently owned by institutional investors.

About Astrana Health

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.